Stephen Belcher is the Founder and CEO of Secure Closure, Inc., where leadership is directed towards creating a large bore vascular closure device for Transcatheter Aortic Valve Implantation (TAVI) and Abdominal Aortic Aneurysm (AAA) femoral artery closures since August 2024. Prior experience includes serving as Senior Director of Marketing and Senior Director of Product Portfolio & New Product Introduction at Anteris Technologies from July 2021 to December 2023, and as Senior Sales Manager for MANTA at Teleflex Incorporated for a brief period in 2019. Stephen held a significant role as Senior Business Development Manager at Edwards Lifesciences from June 2016 to January 2019, and consulted on the global launch of the BioFreedom coronary stent at Biosensors International Group Ltd. Stephen's early career included key positions as Managing Director at Medi-Globe Group and as Marketing Manager at Abbott, focusing on interventional cardiology and vascular closure solutions. Academic credentials comprise a Bachelor of Veterinary Science and a Bachelor of Science in Biochemistry and Physiology, both obtained from Massey University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices